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Abstract
Background: Multidisciplinary team (MDT) meetings are the core mechanism for delivering mental health care but
it is unclear which models improve care quality. The aim of the study was to agree recommendations for improving
the effectiveness of adult mental health MDT meetings, based on national guidance, research evidence and
experiential insights from mental health and other medical specialties.
Methods: We established an expert panel of 16 health care professionals, policy-makers and patient representatives.
Five panellists had experience in a range of adult mental health services, five in heart failure services and six in cancer
services. Panellists privately rated 68 potential recommendations on a scale of one to nine, and re-rated them after
panel discussion using the RAND/UCLA Appropriateness Method to determine consensus.
Results: We obtained agreement (median≥ 7) and low variation in extent of agreement (Mean Absolute Deviation
from Median of ≤1.11) for 21 recommendations. These included the explicit agreement and auditing of MDT meeting
objectives, and the documentation and monitoring of treatment plan implementation.
Conclusions: Formal consensus development methods that involved learning across specialities led to feasible
recommendations for improved MDT meeting effectiveness in a wide range of settings. Our findings may be used by
adult mental health teams to reflect on their practice and facilitate improvement. In some other contexts, the
recommendations will require modification. For example, in Child and Adolescent Mental Health Services, context-
specific issues such as the role of carers should be taken into account. A limitation of the comparative approach
adopted was that only five members of the panel of 16 experts were mental health specialists.
Keywords: Multidisciplinary team, Recommendations, Chronic diseases, Consensus development method, Adult
mental health
Background
Multidisciplinary team (MDT) meetings for chronic dis-
eases are well established in the NHS [1–4] and have
been the core model for delivering mental health care
for decades [5]. However, they are resource intensive,
commonly occupying teams of more than a dozen pro-
fessionals for several hours each week. Moreover, there
is substantial diversity in their perceived purpose and
their organisation, both between mental health teams
and across other chronic disease MDTs [6–9]. This can
partly be explained by variations in guidance provided
for different conditions. Thus, cancer teams follow na-
tional guidance which sets out prescribed features of
MDT meetings with respect to structure, attendance,
documentation of decisions and administrative support.
Cancer MDTs are nationally audited against a detailed list
of indicators relating to these features [1, 10, 11]. In con-
trast, in mental health relatively little national guidance is
* Correspondence: r.raine@ucl.ac.uk
1Department of Applied Health Research, University College London, London
WC1E 7HB, UK
Full list of author information is available at the end of the article
© 2015 Raine et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Raine et al. BMC Psychiatry  (2015) 15:143 
DOI 10.1186/s12888-015-0534-6
available and locally determined arrangements are often
advocated [3, 12]. Where recommendations are made,
they tend to lack specificity. For example, guidance for
Memory Clinics simply states that care plans for patients
should be developed in consultation with a number of dif-
ferent (but unspecified) disciplines [13]. It is telling that in
comparison with teams in other specialities, adult mental
health teams are often idiosyncratic and produce and im-
plement fewer MDT decisions [8].
Variations in team practice may reflect appropriate re-
sponsiveness to local needs, but may also indicate uncer-
tainty or a lack of evidence regarding the most effective
ways to conduct MDT meetings. Policy makers are now
focusing on the need to improve the quality of mental
health service provision through the establishment of a
Mental Health Intelligence Network, based on the can-
cer model, to better monitor variations in provision [14].
In addition, the Care Quality Commission recently com-
mitted to developing definitions of ‘what good looks like’
in mental health services [15]. Enhancing the effectiveness
of the MDT meeting, the key management decision-
making body, is central to improving care overall and re-
ducing unwarranted variations in care.
Uncertainty about determinants of MDT effectiveness
is, in part, secondary to insufficient or inconclusive empir-
ical evidence. One approach to address a lack of research
or research ambiguities is to use formal consensus
methods [16, 17]. These are structured facilitation tech-
niques that measure levels of consensus among experts by
synthesising their opinions [18]. In contrast to informal
decision-making groups such as committees, they follow
explicit steps that can be replicated. They have been used
to formulate clinical practice guidelines and to inform ser-
vice development in mental health [19, 20]. The three
consensus methods most often used in health care re-
search are the Delphi Method, the Nominal Group Tech-
nique, and the RAND/UCLA Appropriateness Method
[16, 21, 22]. In practice, formal consensus studies often
adapt components from each of these approaches to
achieve their aims [17].
We applied the RAND/UCLA Appropriateness Method
(RAM) to examine the extent to which it is possible to de-
rive feasible recommendations for improving the effective-
ness of mental health MDT meetings. This was part of a
larger study aiming to derive recommendations which are
generalisable across MDTs for patients with a range of
common diseases [8]. In addition to adult mental health,
we therefore also examined other disease specialties, en-
suring that we included those for which comprehensive
guidance exists (cancer) and others where it does not
(heart failure). This allowed us to identify areas where spe-
cialities could ‘learn from one another’ and areas where
condition specific recommendations were likely to be re-
quired. In this paper we present recommendations that
can be implemented by adult mental health MDTs to im-
prove their quality. Our focus is on generic recommenda-
tions for the weekly adult mental health meeting typically
attended by the whole multidisciplinary team, rather than
Care Plan Assessments (CPAs) and Mental Health Act as-
sessments, which have specific requirements and formats.
Methods
We convened a panel of experts, which included five
mental health panellists with expertise in adult mental
health care settings. Panellists first rated a series of rec-
ommendations on the basis of the research evidence
which we provided within the context of their experi-
ence of MDT meetings and their expertise and know-
ledge. These ratings were done privately using a postal
questionnaire. This was followed by a meeting during
which panellists revised their ratings in the light of
quantitative feedback on the panel’s initial ratings, a dis-
cussion of the rationale for their judgements, again
within the context of their own experiences [23]. Each
component of this process is described in more detail
below and summarised in Fig. 1.
Generating recommendations for the expert panel to rate
We used the following sources of evidence to generate
recommendations for rating by the expert panel:
Research evidence
We used the results from a large mixed-methods obser-
vational study of 12 MDTs (in adult mental health,
memory, cancer, and heart failure services) which we
had recently undertaken [9]. In this research we exam-
ined the determinants of effective MDT decision-making
and explored areas of diversity in MDT meetings. We
collected data from three sources: non-participant obser-
vation of MDT meetings, semi-structured interviews
with MDT professionals and patients, and clinical data
from medical records. The mental health data in this
study came from observations of the meetings of six
Adult Community Mental Health, Early Intervention in
Psychosis and Memory Clinic teams (all from the North
Thames area of England, held between December 2010
and December 2012), and from semi-structured interviews
with 35 mental health professionals and patients. We gen-
erated recommendations from our quantitative analysis
which identified determinants of implementation of MDT
decisions. We also drew on our qualitative data which ex-
plored specific practices considered effective by some
teams but not used in others, appropriate issues for MDT
discussions, team structure and other MDT features, and
ways to improve MDT meetings and to incorporate pa-
tient preferences into MDT discussions.
In addition, we conducted a review of UK based re-
search literature published between 1995 and May 2013
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on key aspects of MDT meetings, including their pur-
pose, structure, meeting processes, content of discus-
sions, and the role of the patient.
National guidance
We identified key national policies and guidance for men-
tal health [3, 24] and memory clinic [13, 25–28] MDTs, in
addition to guidance for cancer [1, 10, 11, 29–32] and
heart failure MDTs [33–35].
Developing recommendations
Using these data sources, we developed an initial list of
recommendations of potential ways to improve the ef-
fectiveness of MDT meetings. These recommendations
were refined in analytic conferences with all members of
the research team to ensure that they were supported by
the data. We also ensured that each recommendation
was clear and precise and included only one issue for
consideration.
In total we generated 68 recommendations for the ex-
pert panel to rate. These recommendations were grouped
into a 16 section questionnaire, based on categories gener-
ated by a thematic analysis of the data. The final categories
related to MDT purpose, structure, meeting processes,
content of discussions, and the role of the patient (see
Additional file 1).
The questionnaire
Each of the 16 sections in the questionnaire summarised
the policy, guidance and research evidence relating to
each group of recommendations in that section. The full
questionnaire pack is provided in Additional file 2. We
instructed panellists to rate their level of support for
each recommendation, according to its desirability and
feasibility, by drawing on the information provided and
on their own knowledge and experience of MDT meet-
ings in their specialty [36]. Ratings were on a nine-point
Likert Scale, where a rating of 1 indicated that the panel-
list strongly disagreed with the recommendation, a rat-
ing of 5 indicated neither agreement nor disagreement
(i.e. depends on circumstances), a rating of 9 indicated
strong agreement, and ‘don’t know’ indicated that partic-
ipants did not think they were informed enough to re-
spond. An example of a recommendation is provided in
Fig. 2.
Identification and establishment of the consensus
development panel
We purposively sampled 22 health care professionals,
policy-makers and patient representatives from different
Trusts and regions of England, and with MDT experience
of adult mental health, heart failure and cancer. Potential
participants were identified by consulting the project’s
Steering Group and relevant professional organisations.
Fig. 1 Overview of the consensus development method used
Implementation of MDT decisions should be 
audited annually 
Strongly ………………………Strongly  
Disagree                      Agree 
Don’t 
know 
   1   2    3    4    5    6    7    8    9 
Fig. 2 An example of a recommendation included in the questionnaire
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This approach helped to ensure that participants had
credibility as experts in their field and were representative
of their profession [17]. Three patient representatives (in-
cluding a carer for a mental health patient) identified and
recruited by our patient co-applicants, were included to
bring their perspective to the discussion. Sixteen of the in-
dividuals invited agreed to participate, including five men-
tal health experts (one psychiatrist, two psychiatric nurses,
one occupational therapist and one patient representa-
tive). These panellists had expertise in an extensive range
of adult mental health care settings, including adult com-
munity mental health teams, inpatient wards, day hospi-
tals, learning disability teams, rehabilitation and recovery
services, and specialist teams for substance misuse, home-
lessness, and forensic populations. The professional back-
grounds of the other panellists are shown in Additional
file 1.
Expert panel Round One – consensus development
questionnaire
Ten weeks before the consensus development meeting,
panellists were sent the first round questionnaire for
completion in private.
Expert panel Round Two – consensus development meeting
The ratings from Round One were used to develop a
personalised version of the questionnaire for each panel
member (Fig. 3). These showed the participant’s own re-
sponses (in red) and the distribution of responses for all
panellists for each item (in italics above the Likert scale).
This information was distributed to the panellists at
the consensus meeting, which was chaired by the Chief
Investigator who is experienced in facilitating formal
consensus panels. The purpose of this meeting was to
discuss those recommendations where there was a lack
of consensus, to explore causes of divergent responses,
and to identify where the lack of consensus was second-
ary to different interpretations of the recommendations.
Panellists were encouraged to discuss reasons for differ-
ences in ratings before re-rating each item privately. The
facilitator ensured that all participants had an opportun-
ity to contribute during the meeting, and made clear
that participants did not need to conform to the group
view [16]. Where it transpired that disagreement was the
result of differing interpretations, the recommendation
was discussed and new wording agreed to clarify any
ambiguities prior to re-rating. Where there had been
consensus (defined below) in the first round ratings, rec-
ommendations were not discussed individually, although
the broader discussion usually touched on the issues ad-
dressed in these recommendations and panellists were
given the opportunity to comment on all recommenda-
tions before re-rating them.
With the consent of all the panellists, the meeting was
audiotaped and field notes taken to ensure that we could
correctly identify the profession and disease specialty as-
sociated with each discussion point made.
Data entry and analysis
Data entry
Ratings were entered into a database using SPSS version
21 for Windows. There were no missing data. At each
round, we double-checked 25 % of the data entered
against the original paper questionnaires to ensure accur-
acy. No errors were detected.
Analysis of Round One ratings
We measured the spread of responses to each recom-
mendation using RAND guidelines [23]. ‘Consensus’ for
a panel of 16 members is defined as four or fewer panel-
lists rating outside the 3-point region containing the me-
dian (1–3.5, 4–6.5, 7–9; i.e. where at least three-quarters
of respondents rate in the same third of the scale). This
allowed us to prioritise recommendations for discussion
at the consensus meeting. 21 recommendations met this
criterion and these were not discussed individually at the
meeting. The remaining 47 recommendations were dis-
cussed individually.
Analysis of Round Two ratings: quantitative analysis
For each item, we examined the strength of agreement
with each recommendation, and the variation in extent
of agreement among panellists.
The strength of the group’s agreement with each rec-
ommendation was indicated by the median [37]. Me-
dians between 7 and 9 indicated agreement with the
Implementation of MDT decisions should be audited 
annually 
Strongly   …………………………… Strongly  
Disagree                                           Agree  
1 2 2 1 3 5
Don’t 
know 
1 2 3 4 5 6 7 8 9
Fig. 3 An example of a recommendation and rating from Round Two showing the distribution of Round 1 responses in italics above the Likert
scale, and the respondent’s own Round 1 rating in red
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recommendation, medians between 4 and 6.5 indicated
uncertainty, and medians between 1 and 3.5 indicated
disagreement. These ranges cover all possible medians
for a 16 member panel and are based on the defini-
tions provided in the RAM User’s Manual [23].
The group’s variation in extent of agreement was indi-
cated by the mean absolute deviation from the median
(MADM) [37]. This was categorised into low, moderate
and high variation according to thirds of the observed
MADM scores (low <1.11, moderate 1.11-1.75, and high
variation >1.75).
We defined a recommendation as a final recommenda-
tion for improving the effectiveness of MDT meetings if
both agreement (median between 7–9) and low variation
in extent of agreement (MADM <1.11) were present.
Where recommendations were rated ‘uncertain’ (me-
dians 4–6.5) or ‘disagree’ (medians 1–3.5), we cate-
gorised the panellists into mental health, cancer, and
heart failure groups and calculated the median score for
each group. This allowed us to provisionally investigate
whether uncertainty or disagreement might be secondary
to disease specific considerations.
Analysis of Round Two ratings: qualitative analysis
We transcribed the meeting in full. We conducted a the-
matic analysis of the meeting transcript, coding the
panellists’ comments regarding each recommendation to
highlight the range of views about each item discussed
and to identify possible explanations for differences in
ratings. We used the qualitative data to identify whether
there were differences of opinion between the mental
health experts and the experts from the other conditions.
Ethical approval
The study was approved by East London Research Ethics
Committee (10/H0704/68) and the National Information
Governance Board for Health and Social Care (ECC 6–
05 (h)/2010).
Results
Results from the second (i.e. final) round of ratings are
summarised and presented in Tables 1, 2, 3, 4 and 5
below. Of the 68 potential recommendations, only one
needed to be re-worded for clarity before re-rating.
Recommendations where there was agreement and low
variation in extent of agreement
We identified 21 recommendations for which there was
both agreement (median ≥7) and low variation in the ex-
tent of agreement (MADM score <1.11; Table 1). This
included six recommendations relating to the purpose of
the meetings (Table 1, Recommendations 1–6), ten relat-
ing to meeting processes (Table 1, Recommendations 7–
16), two relating to content of the discussion, and three
relating to the role of the patient. Panellists from all spe-
cialties agreed that these recommendations were desirable
and feasible. A printable list of these final recommenda-
tions is also provided in Box 3 of Additional file 1.
Recommendations where there was agreement but high
or moderate variation in the extent of agreement
There were a further 17 recommendations where there
was agreement (medians between 7 and 9) but high or
moderate variation in the extent of that agreement be-
tween panellists (Tables 2 and 3).
Where there were differences in opinion, the qualita-
tive data highlighted that the main concern amongst
panellists was feasibility. For example, some panellists
raised concerns about the feasibility of having a desig-
nated person at each MDT meeting to identify suitable
patients for clinical trials (Recommendation 22), and of
giving patients feedback on all treatment options, even
those rejected by the MDT (Recommendation 23): ‘I just
thought it was impractical…you would be entering into a
very, very, very long conversation, creating a lot of con-
flict, instead of it [the feedback] being [about] the treat-
ment you think is practical and will hopefully work’
(doctor, mental health). Similarly, some panellists thought
that allowing patients to choose the mode of MDT
feedback was impractical: ‘I disagree …we can’t actu-
ally commit to sending everyone written feedback…be-
cause of time constraints’ (team manager, mental health:
Recommendation 24).
Furthermore, mental health panellists did not always
agree with each other. For example there were differ-
ences of opinion about whether all MDTs should have a
dedicated MDT coordinator or administrator (Recom-
mendation 27). While a mental health nurse supported
this recommendation: ‘clinicians end up doing a lot of
work which could easily be done by someone else… [it
would] free up their time’, a mental health doctor argued:
‘I’m not sure that we need them [a dedicated administra-
tor]… the person who’s seen them needs to be able to pull
all that together succinctly and report back to the team,
why do you need someone to coordinate that?’
The qualitative data also identified differences of opin-
ion between mental health panellists and those from
other specialities. For example, a mental health panellist
suggested that rotating responsibility for chairing the
MDT meeting allowed different members of the team to
gain chairing skills: ‘I don’t think it has to be designated,
ours rotates and it works fine. I think we should learn
and have those skills’ (team manager, mental health: Rec-
ommendation 26). In contrast, cancer and heart failure
panellists argued that MDT meetings should have a des-
ignated Chair, or that the role should be restricted to a
small number of people: ‘it’s quite a difficult skill to
chair an MDT well…the MDT becomes temporarily
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dysfunctional for three months whilst someone is thrown
into the position of Chair who doesn’t really want to be
doing it, and doesn’t necessarily have the skills to do it’
(doctor, cancer: Recommendation 26).
Recommendations rated as ‘uncertain’
There were 17 recommendations where the strength of
agreement was ‘uncertain’ (median rating was ≥4 and
≤6.5). However, calculating the median score for panel-
lists from each discipline separately, showed that mental
health panellists had rated ‘agree’ or ‘disagree’ for 13 of
these (Table 4). Five of these 13 recommendations re-
lated to providing patient-centred care, for example,
how information on patients’ psychosocial issues should
be managed and the best ways of facilitating patient in-
put into discussions. In contrast to cancer and heart fail-
ure panellists, mental health panellists agreed with the
recommendation that patients should not be presented
at an MDT meeting unless someone who has met them
is present (Recommendation 51): ‘it’s different [in mental
health], you can’t say anything before you’ve met the pa-
tient’ (doctor, mental health). They also agreed that pa-
tients should only be discussed when their psychosocial
characteristics could be presented (Recommendation
48): ‘patients are people and I think it’s relevant as to
whether their treatment is likely to impact on their social
Table 2 Recommendations where strength of agreement was agree (median ≥7) but variation in extent of agreement was high
(MADM score >1.75)
Recommendation Median Mean absolute
deviation from the
median (MADM)
22 All teams should have a designated person at each MDT meeting to help identify suitable patients for clinical trials 7 1.88
23 Patients should be given feedback on all treatment options, even those rejected by the MDT 7 2.25
24 Patients should be able to choose the mode of MDT meeting feedback (e.g. written, phone call, in clinic) 7.5 2.19
Table 1 The 21 recommendations for improving the effectiveness of mental health multidisciplinary team meetings
Recommendation Median Mean absolute
deviation from the
median (MADM)
1 The primary objective of MDT meetings should be to agree treatment plans for patients. Other functions are
important but they should not take precedence
8 0.88
2 MDT discussions should result in a documented treatment plan for each patient discussed 9 0.56
3 MDT meeting objectives should include locally (as well as nationally) determined goals 8 0.63
4 The objectives of MDT meetings should be explicitly agreed, reviewed and documented by each team 8 0.94
5 Explaining the function of the MDT meeting should be a formal part of induction for new staff 9 0.44
6 There should be a formal mechanism for discussing recruitment to trials in MDT meetings (for example, having
clinical trials as an agenda item)
8 0.81
7 All Chairs should be trained in chairing skills 7 0.81
8 All new patients should be discussed even if a clear protocol exists 8.5 0.94
9 Teams should agree what information should be presented for patients discussed 9 0.56
10 All new team members should be told what information they are expected to present 9 0.38
11 The objectives of the MDT meeting should be reviewed yearly 9 1
12 Once a team has established a set of objectives, the MDT should be audited against these 7.5 0.94
13 All action points should be recorded electronically 9 0.81
14 Implementation of MDT decisions should be audited annually 8 1
15 Where an MDT meeting decision is changed, the reason for changing this should be documented 9 0.19
16 There should be a named implementer documented with each decision 9 0.38
17 Comorbidities should be routinely discussed at MDT meetings 8 0.94
18 Patients’ past medical history should routinely be available at the MDT meeting 8.5 0.56
19 The MDT should actively seek all possible treatment options, and discuss these with the patient after the meeting 9 0.44
20 Patients should be given verbal feedback about the outcome of the MDT meeting 8.5 0.94
21 Where it would be potentially inappropriate to share the content of an MDT discussion with the patient the
decision not to feedback should be formally agreed and noted at the meeting
9 0.63
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life, their quality of life, and in the other direction
whether or not their context is having an impact on their
treatment’ (doctor, mental health).
Similarly, mental health panellists were the only group
who agreed with Recommendations 53, 54 and 55 about
patients being able to provide information to the MDT
by modifying their medical records and providing audio
recorded input: ‘allowing them to present their view-
points…will be further evidence of their state of mind at
the time’ (patient representative, mental health).
On the other hand mental health panellists disagreed
that the objectives of team meetings should be the same
across all chronic diseases (Recommendation 39); ‘in a
mental health MDT…people need some emotional sup-
port in managing a patient who’s quite risky. That might
be very different to a more clinical orientated team who
are really checking that an algorithm has been followed’
(doctor, mental health). Cancer and heart failure panel-
lists disagreed with this, despite MDTs in different con-
ditions being ‘very, very different animals’ (policy maker,
cancer).
Recommendations where there was disagreement
There were 13 recommendations which the panellists
disagreed with (median <4; Table 5). A number of these
centred on the role of the patient in MDT decision-
making. For example panellists from all disease special-
ities pointed to practical and cognitive barriers to asking
patients before the MDT about how much they wish to
be involved in decision-making (Recommendation 63): ‘a
lot of service users have difficulties making decisions’
(team manager, mental health); ‘I’m not sure it’s a ques-
tion that many patients might be able to deal with…es-
pecially…if [they] are presenting with something that
[they] don’t suspect, [they’ve] got so many things to think
about’ (patient representative, cancer). Similarly, the
panel disagreed with Recommendations 65 and 66 that
patients should be allowed to opt out of the meeting,
particularly those at risk of harm: ‘we couldn’t do our
jobs if patients could opt out. It’s not uncommon for
people with mental health problems to not want to have
anything to do with us!’ (doctor, mental health).
For five of the 13 potential recommendations rated as
‘disagree’ overall, the median for mental health panellists
fell into the ‘uncertain’ range (Recommendations 59, 61,
62, 64, and 67).
For example, although the panel as a whole did not
think that all patients should be told if they are going to
be discussed in an MDT meeting (Recommendation 64)
the mental health panellists were uncertain about this
recommendation. In common with cancer panellists, the
mental health experts were also uncertain as to whether
patients should only be discussed if their treatment pref-
erences were known (Recommendation 61): ‘people with
mental health problems don’t always have a strong pref-
erence’ (doctor, mental health).
Finally, mental health panellists were the only group
who were uncertain as to whether patients should be
Table 3 Recommendations where strength of agreement was agree (median ≥7) but variation in extent of agreement was moderate
(MADM score 1.11-1.75)
Recommendation Median Mean absolute
deviation from the
median (MADM)
25 MDT meetings should be a forum for recruiting patients to clinical trials 8 1.19
26 All MDTs should have a designated (rather than a rotating) Chair for MDT meetings 7 1.75
27 All MDTs should have a dedicated MDT coordinator/administrator 9 1.31
28 MDT Chairs should attend at least one other MDT meeting to identify approaches to improve their chairing skills 8 1.56
29 A patient list should be available for all team members to view in advance of an MDT meeting 8.5 1.31
30 Presentations should be explicitly framed in the light of a specific query or issue to be discussed 8 1.13
31 All MDTs should be audited through external peer-review 8.5 1.13
32 There should be time within MDT meetings to discuss current and emerging research and evidence only in
relation to the case discussed
7.5 1.25
33 Relevant psychosocial issues for patients presented to each type of MDT should be identified and agreed by the MDT 7.5 1.44
34 The MDT member who presents the case should routinely consider psychosocial factors and ensure that relevant
information is available at the meeting
8 1.19
35 Teams should be explicit about the research evidence that they are drawing on when making a decision in the
MDT meeting
7 1.25
36 Patients should be given feedback on which professional groups were present when they were discussed at the
MDT meeting
7.5 1.69
37 Patients should be given feedback every time they are discussed at an MDT meeting 8 1.25
38 Patients should be given written feedback about the outcome of the MDT meeting 7 1.63
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given the option of attending MDT meetings (Recom-
mendation 67).
Discussion
We demonstrate that it is possible to use formal consen-
sus development methods to produce feasible recom-
mendations for improving the effectiveness of MDT
meetings in adult mental health services. Expert panel-
lists from mental and physical health backgrounds
agreed with 21 (31 %) of the 68 recommendations
proposed and demonstrated low variation in the extent
of agreement with these 21 recommendations. While
previous research in this area has focused on individual
conditions, our findings illustrate the value of shared
learning across mental and physical health care to agree
core factors for effective MDT functioning [10, 38–40].
Nonetheless, the recommendations would require modi-
fication in some contexts. For example, in Child and
Adolescent services, context-specific issues such as the
role of carers would need to be taken into account.
Table 4 Medians for each disease group: recommendations rated as “uncertain” overalla
Recommendation Overall
median
Mean absolute
deviation from the
median (MADM)
Median amongst
mental health
panellists N = 5
Median amongst
cancer panellists
N = 6
Median amongst
heart failure
panellists N = 5
39 The main objectives of MDT meetings should be the
same across all chronic diseases
6.5 1.88 3 7 7
40 Teaching should be a function of MDT meetings
provided it does not add to the length of meetings
6.5 2.31 8 6 5
41 Teaching should be a function of MDT meetings even
if it means meetings will be longer
5 1.94 7 6 4
42 All treatment plans for existing patients should be
agreed in an MDT meeting even if a clear protocol exists
5 2.06 7 5 2
43 Members should be allowed to not attend as long
as someone from their discipline is attending and
the member does not have a case to present
5 1.75 7 4.5 6
44 A list of people who are required to attend the MDT
meeting should be decided locally by the team
5 2.44 6 2 7
45 A patient should only be discussed at the MDT meeting
when information on comorbidity is available
4.5 2.19 2 6 6
46 A designated MDT member should speak to the patient
about comorbidities before the patient is discussed at
an MDT meeting
4 2.38 6 3.5 3
47 Each MDT should identify the most appropriate methods
for presenting complete information on comorbidities
5 1.13 7 5 5
48 Case presentation should routinely include a brief
introduction of the patient and relevant psychosocial
characteristics, otherwise the case should not be discussed
6 2.38 7 4 3
49 Any MDT member who presents a case should discuss
treatment preferences with the patient before the
MDT meeting
5.5 2.00 7 4.5 7
50 Patient preferences regarding available treatment
options should be discussed with the patient after
(rather than before) the MDT meeting
5.5 1.63 5 6 8
51 Patients should not be presented at the MDT meeting
unless there is someone present who has met with
them at least once before the meeting, even if this
postpones discussion of that patient
5 2.63 8 2 3
52 Patients should be given the opportunity to provide
information in advance of the MDT meeting to ensure
the information presented is accurate and comprehensive
5 2.13 7 4.5 6
53 Patients should be able to provide information by having
direct access and the ability to modify their medical records
5 2.69 7 2 5
54 Patients should be given the option to provide a written
summary for the meeting
5 1.88 6 3.5 3
55 Patients should be given the option to provide audio
recorded input to the meeting
4.5 2.50 7 1.5 3
aIn order to illustrate differences, numbers in green indicate agreement; and numbers in red indicate disagreement
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The largest category of recommendations where there
was cross-specialty agreement related to MDT processes
(10 of the 21 recommendations). Our findings concur
with other research demonstrating the importance of
clear documentation of meeting outcomes [32, 38] and
regular review of meeting objectives [39]. While cancer
MDTs already follow, and are audited against, national
guidelines that explicitly address these issues, [7, 11]
mental health MDTs do not. Our findings demonstrate
agreement among experts that it would be feasible and
desirable for adult mental health MDTs to also adhere to
a number of these processes. Many of these recommen-
dations require minimal additional financial resources,
indicating that improvement is possible even in resource-
stretched teams.
Clarity of purpose has previously been identified as a
key feature of effective team working [39, 40]. However,
it has been reported that mental health staff are some-
times unclear about the purpose of MDT meetings [8, 40].
We obtained consensus regarding their principal objective
(i.e. the agreement of treatment plans) and agreement for
the inclusion of both locally and nationally determined
goals.
Previous research has emphasised the importance of
considering patient preferences and noted the associ-
ation with better MDT decision implementation rates
[41–43]. However a recent survey of mental health ser-
vice users by the Care Quality Commission found that
only 57 % agreed that they were ‘definitely’ involved as
much as they wanted to be in agreeing what care they
Table 5 Medians for each disease group: recommendations rated “disagree” overalla
Question Overall
median
Mean absolute
deviation from the
median (MADM)
Median amongst
mental health
panellists N = 5
Median amongst
cancer panellists
N = 6
Median amongst
heart failure
panellists N = 5
56 MDT meetings should be a forum for brainstorming and
giving advice without necessarily reaching a decision
3 1.25 3 3 2
57 Only complex cases should be discussed in the MDT
meetings (regardless of whether they are new or
existing patients)
3 1.31 3 2 3
58 It is more important to discuss all patients, even if
superficially, than it is to discuss a smaller number
of patients in more depth
3.5 1.69 2 5 2
59 There should be time within MDT meetings to discuss
current and emerging research and evidence which is
not specifically related to an individual case
3.5 2.38 6 3.5 3
60 Members should be allowed to join the meeting for
cases that are relevant to them and leave after the
discussion of these
3 1.19 3 3 3
61 Patients’ treatment preferences should be routinely
discussed at the MDT meeting and if not available
the case should not be discussed
3 1.94 5 4 2
62 Patient preferences regarding available management
options should be reported to the MDT meeting only
if the clinician responsible for their care thinks it will
alter the decision
3 2.00 5 3.5 2
63 Patients should be asked before the MDT how much
they want to be involved in decision-making about
their treatment
3 1.88 3 2.5 3
64 All patients should be told if they are going to be
discussed at an MDT meeting before the meeting
otherwise they should not be discussed
2 1.88 5 1 2
65 All patients should be explicitly given the choice of
whether or not to be discussed at the MDT meeting
1.5 1.19 2 1 1
66 Patients should not be given an explicit choice, but if
they express concern about being discussed at the
MDT meeting they should be allowed to opt out
2 1.25 2 2 5
67 Patients should be given the option of attending
MDT meetings
1 1.19 5 1 1
68 Patients should be given MDT meeting feedback
only when decisions are made about their care
3 1.06 3 3 5
aStrength of agreement was agree for medians 7 - 9; uncertain for medians 4 - 6.5 and disagree for medians 1 - 3.5
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will receive [44]. The expert panel discussed the import-
ance of knowing patient preferences in advance of MDT
meetings and of shared decision-making. Much of the
discussion highlighted the complexity of these issues in
terms of the most appropriate way to involve patients,
and practical constraints such as the need to use invol-
untary treatment. The panel therefore recommended
that when making a decision, the MDT should actively
seek to identify all possible treatment options and dis-
cuss these with the patient after the meeting.
Adult mental health MDTs have certain distinctive fea-
tures which explain why there was disagreement with
some proposed recommendations. For example, panel-
lists disagreed that patients should be allowed to opt out
of being discussed at MDT meetings, citing concerns
about the impact of this on patients at risk of harm. This
may be particularly problematic if patients are unable to
fully discern the adverse implications of their condition.
In addition, panellists did not think that the MDT meet-
ing should be a forum for the discussion of complex
cases only.
We also identified areas where it is likely that mental
health specific recommendations are required. For ex-
ample, mental health panellists considered it to be im-
perative for someone with personal knowledge of a
patient to be present when that patient is discussed by
the MDT, whereas this was thought to be unnecessary in
cancer and heart failure MDT meetings.
Strengths and limitations
The novel inclusion of research evidence, policy and
clinical expertise from across mental and physical health
care was a key strength in this study. Highlighting the
evidence and guidance available from other specialities,
and bringing together diverse experts to share their dif-
ferent experiences, encouraged new perspectives on
taken-for-granted practices and challenged assumptions
regarding what can feasibly be achieved in MDT meet-
ings. This approach allowed us to apply learning from
different disease specialities to agree recommendations
which might be applied generically across conditions.
Our recommendations do not displace specific consider-
ations which must be applied during CPA and Mental
Health Act Assessments, e.g. to ensure safeguarding or
to assess risk of harm to self and others. Our study de-
sign also allowed us to distinguish those issues which
might be more appropriately dealt with on a condition-
specific basis. A limitation of this comparative approach
was that the panel of 16 experts included just five men-
tal health specialists. The size of the panel was deter-
mined by the evidence that whilst having more group
members increases the reliability of group judgement,
large groups reduce the ability to elicit sufficient contri-
butions from every member of the panel [17]. Whilst we
acknowledge that five mental health panellists cannot
encompass the variety of MDT meetings in mental
health services, this limitation is likely to impact upon
our provisional results referring to recommendations
that may be better made on a condition specific basis.
We therefore suggest that further examination by homo-
geneous (mental health) consensus development panels
is needed to explicitly define those purposes and pro-
cesses which are specific to mental health MDTs.
Another important strength of our study was our cal-
culation of both the strength and extent of agreement
for each recommendation. The extent (or spread) of the
distribution of ratings tends to attract relatively little at-
tention but its measurement was particularly relevant in
this study because it depends on group composition
[37]. Low variation in the spread of ratings was achieved
in 21 recommendations which the panel agreed with.
This suggests that experts from different clinical back-
grounds took account of other’s opinions [45].
We chose to use the RAND/UCLA Appropriateness
Method (RAM) rather than the more commonly used
Delphi consensus development survey. Whilst the Delphi
approach enables large sample sizes, the RAM allowed us
to explore the rationale behind panellists’ ratings by quali-
tatively analysing the panel discussion. The level of detail
provided in this face-to-face discussion enabled the pro-
duction of far more informative results than would have
been possible with a Delphi survey. Furthermore, to miti-
gate the possibility that the presentation and framing of
the research evidence might influence judgements [46] we
used the meeting to identify any differing interpretations
of the information provided. This resulted in the reword-
ing of just one recommendation to clarify its meaning
(Recommendation 19). Finally, the panel discussion en-
sures that the final recommendations are concise and
clear.
In determining the composition of our expert panel,
we aimed to include as diverse an array of relevant
‘voices’ as possible to facilitate the exploration of com-
prehensive perspectives. Whilst we succeeded in includ-
ing clinical, patient and policy representatives, we were
unable to represent all relevant professional groups (for
example, psychologists) or a wider range of patient rep-
resentatives. This was partly because not all of the pro-
fessionals who we approached accepted our invitation to
participate, and partly because we needed to limit the
number of participants included in the single panel
meeting to ensure that all those present could fully par-
ticipate and be heard. However an important adverse
consequence was the limited patient voice. The com-
plexity of involving patients and carers in decisions
about their care was recognised by the panel and in the
results relating to the role of the patient. The reliability
of our results could be tested by conducting a large scale
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Delphi survey of a wider range of relevant ‘stakeholders’,
including patients and carers [47].
Finally, audit of implemented recommendations is re-
quired to ascertain their effectiveness in practice.
Conclusions
The availability of explicit guidance for ensuring the ef-
fectiveness of MDT meetings varies widely across mental
and physical health conditions. In adult mental health
care, the purpose and format of MDT meetings is largely
locally formulated, while cancer teams are required to
adhere to explicit, nationally determined guidance. It is
tempting to justify this difference as an inevitable conse-
quence of different disease trajectories, funding systems,
patient and research contexts. Whilst it is to be expected
that some disease specific guidance is necessary, our use
of a formal consensus development technique enabled
us to identify 21 feasible recommendations for improv-
ing the effectiveness of MDT meetings in a range of set-
tings, including adult mental health. Comparing MDT
meetings in different specialties allowed alternative ‘pat-
terns of thinking’ to be revealed and scrutinised, prompt-
ing critical reflection on established and taken-for-granted
beliefs and practices. Enhancing the effectiveness and
productivity of the MDT meeting is particularly salient
given the centrality of this decision-making model in the
NHS and the escalating mental health burden as a propor-
tion of all NHS activity. Thus, the application of these rec-
ommendations is important because MDT meetings are
extremely resource intensive and their value to the NHS
and individual patients should be maximised.
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